Matter L, Bally F, Germann D, Schopfer K
Institute for Medical Microbiology, University of Berne, Switzerland.
Eur J Epidemiol. 1995 Jun;11(3):305-10. doi: 10.1007/BF01719435.
We have collected data on the incidence of rubella in Switzerland from 1987 to 1992 to help evaluating the impact of the measles, mumps and rubella (MMR) mass vaccination programme which started in 1985 in this country. We used detailed informations on samples submitted for diagnostic testing in conjunction with anonymous laboratory notifications to the Swiss Federal Office for Public Health, and data from the Swiss sentinel network of general practitioners to find trends in the incidence of rubella after the introduction of mass vaccination. We observed an unabated seasonal oscillation without decreasing trend during the observation period and were unable to detect a shift in the age distribution of cases. An important proportion of laboratory-confirmed rubella occurred in women of childbearing age. Immigrants from regions with low endemicity of rubella were at increased risk of contracting rubella and transmitting it to their offspring. We conclude, that MMR mass vaccination has not interrupted the circulation of rubella virus in Switzerland, and that improvements in the implementation and surveillance of the MMR vaccination campaign are necessary in order to avoid untoward effects of it.
我们收集了1987年至1992年瑞士风疹发病率的数据,以帮助评估该国1985年开始的麻疹、腮腺炎和风疹(MMR)大规模疫苗接种计划的影响。我们结合向瑞士联邦公共卫生局提交的匿名实验室报告,利用提交用于诊断检测的样本的详细信息,以及瑞士全科医生哨点网络的数据,来发现大规模疫苗接种引入后风疹发病率的趋势。我们观察到在观察期内季节性波动未减弱且无下降趋势,并且未能检测到病例年龄分布的变化。实验室确诊的风疹病例中有很大一部分发生在育龄妇女中。来自风疹低流行地区的移民感染风疹并将其传播给后代的风险增加。我们得出结论,MMR大规模疫苗接种并未中断瑞士风疹病毒的传播,为避免其不良影响,有必要改进MMR疫苗接种活动的实施和监测。